公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | CHENG-HONG TSAI ; JIH-LUH TANG ; FENG-MING TIEN ; YUAN-YEH KUO ; Wu D.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; CHIA-WEN LIU ; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood Advances | 27 | 27 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2022 | Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma | Hsu C.-J.; HSIN-AN HOU ; CHANG-PING LIN ; Lee Y.-J.; Hsu W.-F.; PO-TING YEH | Journal of the Formosan Medical Association | 1 | 1 | |
2016 | Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection | WEI-LI MA ; HSIN-AN HOU ; Hsu, Ya-Jui; YIN-KAI CHEN ; JIH-LUH TANG ; WOEI TSAY ; PO-TING YEH ; CHUNG-MAY YANG ; CHANG-PING LIN ; HWEI-FANG TIEN | Annals of Hematology | 43 | 37 | |
2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
2017 | Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia | HSIN-AN HOU ; Lu J.-W.; Lin T.-Y.; CHENG-HONG TSAI ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; YUAN-YEH KUO ; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; JIH-LUH TANG ; Gong Z.; LIANG-IN LIN ; HWEI-FANG TIEN | Blood cancer journal | 15 | | |
2023 | Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; FENG-MING TIEN ; Lo, Min-Yen; Ni, Sao-Chih; MING YAO ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 3 | |
2016 | Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia | Madan V.; Shyamsunder P.; Han L.; Mayakonda A.; Nagata Y.; Sundaresan J.; Kanojia D.; Yoshida K.; Ganesan S.; Hattori N.; Fulton N.; Tan K.-T.; Alpermann T.; Kuo M.-C.; Rostami S.; Matthews J.; Sanada M.; Liu L.-Z.; Shiraishi Y.; Miyano S.; Chendamarai E.; HSIN-AN HOU ; Malnassy G.; Ma T.; Garg M.; Ding L.-W.; Sun Q.-Y.; Chien W.; Ikezoe T.; Lill M.; Biondi A.; Larson R.A.; Powell B.L.; Lübbert M.; Chng W.J.; HWEI-FANG TIEN ; Heuser M.; Ganser A.; Koren-Michowitz M.; Kornblau S.M.; Kantarjian H.M.; Nowak D.; Hofmann W.-K.; Yang H.; Stock W.; Ghavamzadeh A.; Alimoghaddam K.; Haferlach T.; Ogawa S.; Shih L.-Y.; Mathews V.; Koeffler H.P. | Leukemia | 95 | 64 | |
2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
2020 | Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax | Wang, Yu-Wen; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; FENG-MING TIEN ; Chen, Yu-Wen; HSIN-YI LIN ; MING YAO ; YUN-CHU LIN ; Lin, Chien-Ting; Chieh-Lung Cheng ; JIH-LUH TANG ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Annals of hematology | 52 | 53 | |
2011 | Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; JIH-LUH TANG ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; HWEI-FANG TIEN | British Journal of Cancer | 31 | 28 | |
2017 | The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model | Hsu Y.-C.; Chiu Y.-C.; CHIEN-CHIN LIN ; Kuo Y.-Y.; HSIN-AN HOU ; Tzeng Y.-S.; Kao C.-J.; Chuang P.-H.; Tseng M.-H.; Hsiao T.-H.; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Journal of Hematology and Oncology | 37 | 32 | |
2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
2021 | Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 | Wang, Yu-Hung; CHIEN-CHIN LIN ; CHIA-LANG HSU ; SHENG-YU HUNG ; CHI-YUAN YAO ; Lee, Sze-Hwei; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Annals of hematology | 19 | 19 | |
2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 5 | 6 | |
2022 | Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Wang, Yu-Hung; CHI-YUAN YAO ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hsu, Cheng-An; Sun, Hsun-I; Chuang, Yi-Kuang; Hsu, Chia-Lang; FENG-MING TIEN ; Tsai, Cheng-Hong; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Hematological oncology | 0 | 0 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |